---
figid: PMC8079203__BMRI2021-5556306.008
figtitle: PI3K/AKT/mTOR and autophagy signal pathway
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC8079203
filename: BMRI2021-5556306.008.jpg
figlink: pmc/articles/PMC8079203/figure/fig8/
number: F8
caption: Schematic diagram of the PI3K/AKT/mTOR and autophagy signal pathway. The
  combination of growth factors and receptors activates the cascade of the PI3K signaling
  pathway and promotes cell survival, proliferation, and migration. In cell-cycle
  regulation, GSK3β reduces the expression of cyclin D1, thereby inhibiting Rb phosphorylation
  and blocking the cell cycle. In HCC cells that have chemotherapy resistance to sorafenib,
  the use of sorafenib can abnormally activate PI3K/AKT/mTOR and induce insignificant
  autophagy. Sorafenib combined with BEZ235 targets a variety of molecules, inhibits
  PI3K, and enhances autophagy to inhibit cell proliferation, migration, and cell-cycle
  progression. Activation of caspase-9 and caspase-7 leads to cell apoptosis.
papertitle: BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib
  by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.
reftext: Weiya Cao, et al. Biomed Res Int. 2021;2021:5556306.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9356648
figid_alias: PMC8079203__F8
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC8079203__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8079203__BMRI2021-5556306.008.html
  '@type': Dataset
  description: Schematic diagram of the PI3K/AKT/mTOR and autophagy signal pathway.
    The combination of growth factors and receptors activates the cascade of the PI3K
    signaling pathway and promotes cell survival, proliferation, and migration. In
    cell-cycle regulation, GSK3β reduces the expression of cyclin D1, thereby inhibiting
    Rb phosphorylation and blocking the cell cycle. In HCC cells that have chemotherapy
    resistance to sorafenib, the use of sorafenib can abnormally activate PI3K/AKT/mTOR
    and induce insignificant autophagy. Sorafenib combined with BEZ235 targets a variety
    of molecules, inhibits PI3K, and enhances autophagy to inhibit cell proliferation,
    migration, and cell-cycle progression. Activation of caspase-9 and caspase-7 leads
    to cell apoptosis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pik3r1
  - Mtor
  - Atg5
  - Mmp2
  - Mmp9
  - Casp9
  - Casp7
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BECN1
  - MTOR
  - ATG5
  - MMP2
  - MMP9
  - Tyrosine
  - Sorafenib
  - BEZ235
---
